CAR T-Cell Therapies
Dec 22, 2025
CAR-T Beyond Cancer: Resetting Immunity in Autoimmune Diseases
Chimeric Antigen Receptor T-cell (CAR-T) therapy has established itself as one of the most disruptive innovations in modern medicine. Since the first approval in 2017, CAR-T therapies have transformed outcomes in hematologic malignancies, achieving deep, durable remissions in patient populations previously resistan...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
